Initiation and Single Dispensing in Cardiovascular and Insulin Medications: Prevalence and Explanatory Factors.
Int J Environ Res Public Health
; 17(10)2020 05 12.
Article
em En
| MEDLINE
| ID: mdl-32408626
ABSTRACT
BACKGROUND:
Adherence problems have negative effects on health, but there is little information on the magnitude of non-initiation and single dispensing.OBJECTIVE:
The aim of this study was to estimate the prevalence of non-initiation and single dispensation and identify associated predictive factors for the main treatments prescribed in Primary Care (PC) for cardiovascular disease (CVD) and diabetes.METHODS:
Cohort study with real-world data. Patients who received a first prescription (2013-2014) for insulins, platelet aggregation inhibitors, angiotensin-converting enzyme inhibitors (ACEI) or statins in Catalan PC were included. The prevalence of non-initiation and single dispensation was calculated. Factors that explained these behaviours were explored.RESULTS:
At three months, between 5.7% (ACEI) and 9.1% (antiplatelets) of patients did not initiate their treatment and between 10.6% (statins) and 18.4% (ACEI) filled a single prescription. Body mass index, previous CVD, place of origin and having a substitute prescriber, among others, influenced the risk of non-initiation and single dispensation.CONCLUSIONS:
The prevalence of non-initiation and single dispensation of CVD medications and insulin prescribed in PC in is high. Patient and health-system factors, such as place of origin and type of prescriber, should be taken into consideration when prescribing new medications for CVD and diabetes.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fármacos Cardiovasculares
/
Doenças Cardiovasculares
/
Diabetes Mellitus
/
Adesão à Medicação
/
Hipoglicemiantes
/
Insulina
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article